T he editors of The Annals are honored to announce Dennis K Helling PharmD FCCP FASHP as the fourth chairman of the Editorial Board beginning November 1, 2003 . Detailed information about Helling's career and impact on pharmacy appears below, and an editorial regarding the changing face of the Board appears following this editorial announcement.
The history of the concept of an advisory board for The Annals began in 1967 with the founding of the journal under the name of Drug Intelligence. With the first issue, the founder and editor, Donald E Francke DSc, appointed 23 contributing editors from the profession to assist in guiding the journal. Eight years later, Francke created an Editorial Advisory Board consisting of 24 members in addition to the 2 dozen editors who initially had been giving the journal advice and direction. Francke explained his idea by stating, "The principal purpose of these appointments is to provide greater grassroots input into the clinical pharmacy movement." 1 One of the journal's original and continuing goals has been the integration of pharmacy and medical practice. As Francke said in his first editorial, "pharmacists must be encouraged to relate more to the patient, the physician, and the nurse and to take his place on the health-care team." He added that one of the objectives of the journal is, "to encourage the development of specialization." 2 Two years later when the name of the journal was changed to Drug Intelligence and Clinical Pharmacy, Francke again emphasized this point by saying, "The journal will continue to be interdisciplinary in nature and of interest not only to the clinical pharmacist but to the physician and nurse as well." Then he elaborated on the changing role of the pharmacist:
"This role will evolve gradually as the pharmacist continues to work closely with physicians and nurses in a patient care setting." 3 Although the goals of The Annals have remained basically the same, the profession and the journal have matured immeasurably. Integration and specialization are readily apparent in the character of the new Editorial Board. The first board in 1975 had no physician members and no specialties designated. In the next year, 2 physicians were added to the board. Specialization of the board began in 1980 and, at that time, there were 24 specialty panels. The Editorial Board effective with this issue has 23 physicians and 67 specialty panels.
We anticipate this maturation will continue under the leadership and direction of Helling and the new members of the board. The journal owes a debt of gratitude to the first chairman, Donald C McLeod MS, who was appointed in 1979, to Peter H Vlasses PharmD BCPS FCCP appointed in 1987, and most recently to Barbara J Zarowitz PharmD BCPS FCCP FCCM appointed in June 1999. These chairmen and their respective board members, in addition to the earlier members and consulting editors, must be given credit for the vast improvements in The Annals since it was established.
Helling's Accomplishments
Dennis K Helling PharmD FCCP FASHP is the Executive Director of Pharmacy Operations and Therapeutics for Kaiser Permanente in Denver, CO. His Pharmacy Department employs more than 600 staff at its 21 pharmacies, emphasizing expanded roles for pharmacists and ambulatory clinical services. Helling's department is recognized for innovative pharmacy services in managed care.
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